CEO Robert Musslewhite resigned effective Jan 16, 2024; departure is without cause; receives 15 months accelerated vesting and up to $15K in legal fees.
Founder and Executive Chairman Jason Krantz appointed interim CEO, effective Jan 16, 2024; Board engaged search firm for permanent CEO.
Company reaffirms Q4 2023 guidance provided on Nov 3, 2023; preliminary 2024 guidance: revenue growth 5-7% YoY, Adj. EBITDA margin +~200 bps.
Krantz previously served as CEO from 2011 to Aug 2022, scaling the company to >$200M revenue and IPO in Sept 2021.
On January 12, 2024, the Company’s Board of Directors appointed Jason Krantz, the Company’s founder and Executive Chairman, as Interim Chief Executive Officer, effective January 16, 2024.
On January 16, 2024, the Company announced that Robert Musslewhite has stepped down as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors, effective January 16, 2024
Key facts
Extracted from this filing and checked against the source text.
Earnings ReleasesSEC 8-K Item 2.02confidence 0.85
Definitive Healthcare Corp. updated its the quarter ended December 31, 2023 guidance (reaffirmed).
Period
the quarter ended December 31, 2023
Guidance
reaffirmed
Result
reported results
Exact text from the filing
On January 16, 2024, Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) issued a press release announcing the management changes described in Item 5.02 below and its reaffirmation of previously announced guidance for the quarter ended December 31, 2023.
Jason Krantz was appointed as Interim Chief Executive Officer at Definitive Healthcare Corp..
Action
appointed
Role
Interim Chief Executive Officer
Exact text from the filing
On January 12, 2024, the Company’s Board of Directors appointed Jason Krantz, the Company’s founder and Executive Chairman, as Interim Chief Executive Officer, effective January 16, 2024.
Robert Musslewhite departed as Chief Executive Officer at Definitive Healthcare Corp..
Action
stepped down
Role
Chief Executive Officer
Exact text from the filing
On January 16, 2024, the Company announced that Robert Musslewhite has stepped down as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors, effective January 16, 2024
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.